Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer.
Scognamiglio I, Cocca L, Puoti I, Palma F, Ingenito F, Quintavalle C, Affinito A, Roscigno G, Nuzzo S, Chianese RV, Belli S, Thomas G, Schomann T, Chan A, Stoppelli MP, Condorelli G. Scognamiglio I, et al. Among authors: puoti i. Mol Ther Nucleic Acids. 2022 Feb 22;28:17-31. doi: 10.1016/j.omtn.2022.02.013. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35317202 Free PMC article.
Erratum: Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer.
Scognamiglio I, Cocca L, Puoti I, Palma F, Ingenito F, Quintavalle C, Affinito A, Roscigno G, Nuzzo S, Chianese RV, Belli S, Thomas G, Schomann T, Chan A, Stoppelli MP, Condorelli G. Scognamiglio I, et al. Among authors: puoti i. Mol Ther Nucleic Acids. 2022 Aug 26;29:656. doi: 10.1016/j.omtn.2022.08.023. eCollection 2022 Sep 13. Mol Ther Nucleic Acids. 2022. PMID: 36090750 Free PMC article.
MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
Roscigno G, Puoti I, Giordano I, Donnarumma E, Russo V, Affinito A, Adamo A, Quintavalle C, Todaro M, Vivanco MD, Condorelli G. Roscigno G, et al. Among authors: puoti i. Oncotarget. 2017 Mar 21;8(12):19507-19521. doi: 10.18632/oncotarget.14470. Oncotarget. 2017. PMID: 28061479 Free PMC article.
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G, Quintavalle C, Donnarumma E, Puoti I, Diaz-Lagares A, Iaboni M, Fiore D, Russo V, Todaro M, Romano G, Thomas R, Cortino G, Gaggianesi M, Esteller M, Croce CM, Condorelli G. Roscigno G, et al. Among authors: puoti i. Oncotarget. 2016 Jan 5;7(1):580-92. doi: 10.18632/oncotarget.5979. Oncotarget. 2016. PMID: 26556862 Free PMC article.
RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway.
Adamo A, Fiore D, De Martino F, Roscigno G, Affinito A, Donnarumma E, Puoti I, Ricci Vitiani L, Pallini R, Quintavalle C, Condorelli G. Adamo A, et al. Among authors: puoti i. Oncotarget. 2017 Feb 21;8(8):13476-13487. doi: 10.18632/oncotarget.14564. Oncotarget. 2017. PMID: 28086236 Free PMC article.